|
2017 Conference Publication Real World Evaluation of Major Bleeding Risk and Costs for All Causes and Bleeding-Related Health Services Among Elderly Patients with Nonvalvular Atrial Fibrillation Treated with Apixaban or WarfarinDeitelzweig, Steven, Luo, Xuemei, Gupta, Kiran, Trocio, Jeffrey, Mardekian, Jack, Cutice, Tammy, Lingohr-Smith, Melissa, Menges, Brandy and Lin, Jay (2017). Real World Evaluation of Major Bleeding Risk and Costs for All Causes and Bleeding-Related Health Services Among Elderly Patients with Nonvalvular Atrial Fibrillation Treated with Apixaban or Warfarin. 66th Annual Scientific Session and Expo of the American College of Cardiology (ACC), Washington DC, United States, Mar 17-19, 2017. San Diego, United States: Elsevier. |
|
2016 Conference Publication An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulantsDeitelzweig, Steve, Bruno, Amanda, Trocio, Jeffrey, Tate, Natalie, Gupta, Kiran, Lin, Jay and Lingohr-Smith, Melissa (2016). An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants. Abingdon, Oxfordshire, United Kingdom: Taylor & Francis. doi: 10.1185/03007995.2015.1131676 |
|
2016 Conference Publication Hospital resource utilization, cost and inpatient mortality associated with hospitalizations for major bleeding among atrial fibrillation patients treated with factor Xa inhibitorsDeitelzweig, S., Neuman, R., Lingohr-Smith, M. and Lin, J. (2016). Hospital resource utilization, cost and inpatient mortality associated with hospitalizations for major bleeding among atrial fibrillation patients treated with factor Xa inhibitors. Congress of the European-Society-of-Cardiology (ESC), Rome Italy, Aug 27-31, 2016. OXFORD: OXFORD UNIV PRESS. |
|
2016 Conference Publication Hospital Length Of Stay And Hospitalization Costs For Pulmonary Embolism Comparing Patients Receiving Rivaroxaban Or WarfarinKline, J. A., Deitelzweig, S., Margolis, J. M., Raut, M., Tran, O., Smith, D. M., Crivera, C., Bookhart, B., Schein, J. and Olson, W. (2016). Hospital Length Of Stay And Hospitalization Costs For Pulmonary Embolism Comparing Patients Receiving Rivaroxaban Or Warfarin. International Conference of the American-Thoracic-Society (ATS), San Francisco, United States, May 13-18, 2016. NEW YORK: AMER THORACIC SOC. |
|
2016 Conference Publication Comparison of rivaroxaban or warfarin use for venous thromboembolism on inpatient length of stayDeitelzweig, Steven, Kline, Jeffrey, Margolis, Jay M., Raut, Monika, Tran, Oth, Smith, David, Crivera, Concetta, Bookhart, Brahim, Schein, Jeff and Olson, William (2016). Comparison of rivaroxaban or warfarin use for venous thromboembolism on inpatient length of stay. 65th Annual Scientific Session and Expo of the American College of Cardiology (ACC), Chicago, United States, April 02-04, 2016. San Diego, United States: Elsevier. doi: 10.1016/S0735-1097(16)32066-6 |
|
2016 Conference Publication Hospital readmissions among patients with nonvalvular atrial fibrillation treated with the new oral anticoagulants, apixaban, dabigatran, and rivaroxabanDeitelzweig, Steven, Gupta, Kiran, Nadkarni, Anagha, Trocio, Jeffrey, Lin, Jay and Lingohr-Smith, Melissa (2016). Hospital readmissions among patients with nonvalvular atrial fibrillation treated with the new oral anticoagulants, apixaban, dabigatran, and rivaroxaban. 65th Annual Scientific Session and Expo of the American College of Cardiology (ACC), Chicago, United States, April 02-04, 2016. San Diego, United States: Elsevier. doi: 10.1016/S0735-1097(16)30806-3 |
|
2016 Conference Publication Health Care Costs Among Patients Diagnosed with Deep Vein Thrombosis in the Outpatient Setting and Treated with Rivaroxaban Versus Low-Molecular-Weight Heparin and WarfarinDeitelzweig, S., Laliberte, F., Raut, R., Germain, G., Bookhart, B. K., Olson, W. H., Schein, J. and Lefebvre, P. (2016). Health Care Costs Among Patients Diagnosed with Deep Vein Thrombosis in the Outpatient Setting and Treated with Rivaroxaban Versus Low-Molecular-Weight Heparin and Warfarin. ISPOR 21st Annual International Meeting, Washington, DC United States, 21 – 25 May 2016. New York, NY United States: Elsevier. doi: 10.1016/j.jval.2016.03.102 |
|
2016 Conference Publication Compare major bleeding risk and associated costs among Nvaf patients with Cha2Ds2-vasc score >= 3 newly anticoagulated with apixaban versus warfarinDeitelzweig, Steven, Gupta, Kiran, Ogbonnaya, Augustina, Shah, Manan, Farrelly, Eileen, Lokhandwala, Tasneem, Eaddy, Michael and Squibb, Bristol-Myers (2016). Compare major bleeding risk and associated costs among Nvaf patients with Cha2Ds2-vasc score >= 3 newly anticoagulated with apixaban versus warfarin. 65th Annual Scientific Session and Expo of the American College of Cardiology (ACC), Chicago, United States, April 02-04, 2016. San Diego, United States: Elsevier. doi: 10.1016/S0735-1097(16)30877-4 |
|
2015 Conference Publication A Conservative Aproach to Assess Warfarin Time-in-Therapeutic Ranges Among Nonvalvular Atrial Fibrillation Patients in An Integrated Healthcare Delivery System Setting in the U.SDeitelzweig, S., Evans, M., Hillson, E., Trocio, J., Bruno, A., Tan, W., Lingohr-Smith, M. and Lin, J. (2015). A Conservative Aproach to Assess Warfarin Time-in-Therapeutic Ranges Among Nonvalvular Atrial Fibrillation Patients in An Integrated Healthcare Delivery System Setting in the U.S. ISPOR 20th Annual International Meeting, Philadelphia, PA United States, 16-20 May 2015. New York, NY United States: Elsevier. doi: 10.1016/j.jval.2015.03.848 |
|
2015 Conference Publication Comparison of Major Bleeding Risk and Associated Costs Among Newly Anticoagulated Non-valvular Atrial Fibrillation PatientsDeitelzweig, Steven, Bruno, Amanda, Tate, Natalie, Ogbonnaya, Augustina, Shah, Manan, Farrelly, Eileen, Lokhandwala, Tasneem, Gupta, Kiran and Eaddy, Michael (2015). Comparison of Major Bleeding Risk and Associated Costs Among Newly Anticoagulated Non-valvular Atrial Fibrillation Patients. Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association (AHA), Orlando, United States, Nov 07-11, 2015. LIPPINCOTT WILLIAMS & WILKINS. |
|
2015 Conference Publication Major bleeding, hospitalisation rates and healthcare costs among non-valvular atrial fibrillation patients naive to oral anticoagulation and newly treated with novel oral anticoagulantsDeitelzweig, S., Bruno, A., Tate, N., Ogbonnaya, A., Shah, M., Farrelly, E., Lokhandwala, T., Gupta, K. and Eaddy, M. (2015). Major bleeding, hospitalisation rates and healthcare costs among non-valvular atrial fibrillation patients naive to oral anticoagulation and newly treated with novel oral anticoagulants. Congress of the European-Society-of-Cardiology (ESC), London, England, United Kingdom, Aug 29-Sep 02, 2015. OXFORD: OXFORD UNIV PRESS. |
|
2015 Conference Publication Early assessment of bleeding-related hospital readmissions among nonvalvular atrial fibrillation patients treated with the new oral anticoagulants using an electronic medical record database in the USDeitelzweig, S., Bruno, A., Trocio, J., Tate, N., Gupta, K., Lin, J. and Lingohr-Smith, M. (2015). Early assessment of bleeding-related hospital readmissions among nonvalvular atrial fibrillation patients treated with the new oral anticoagulants using an electronic medical record database in the US. Congress of the European-Society-of-Cardiology (ESC), London, England, United Kingdom, Aug 29-Sep 02, 2015. OXFORD: OXFORD UNIV PRESS. |
|
2014 Conference Publication Evaluation of Differences in Medical Costs Associated with Venous Thromboembolism Prophylaxis with Desirudin Vs. Low Molecular Weight Heparin Among Patients Undergoing Total Hip Replacement SurgeryDeitelzweig, Steven, Nutescu, Edith A., Meyer, James, Lin, Jay, Lingohr-Smith, Melissa and Amin, Alpesh N. (2014). Evaluation of Differences in Medical Costs Associated with Venous Thromboembolism Prophylaxis with Desirudin Vs. Low Molecular Weight Heparin Among Patients Undergoing Total Hip Replacement Surgery. 56th Annual Meeting of the American-Society-of-Hematology, San Francisco Ca, Dec 06-09, 2014. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2013 Conference Publication Costs of Patients with Nonvalvular Atrial Fibrillation Who Have Bleeding Events in a Large Managed Care PopulationDeitelzweig, Steven, Pinsky, Brett, Buysman, Erin, Lacey, Michael, Jing, Yonghua, Wiederkehr, Daniel and Graham, John (2013). Costs of Patients with Nonvalvular Atrial Fibrillation Who Have Bleeding Events in a Large Managed Care Population. 62nd Annual Scientific Session of the American-College-of-Cardiology, San Francisco Ca, Mar 09-11, 2013. ELSEVIER SCIENCE INC. |
|
2012 Conference Publication Association Between Age and Bleeding Events of Different Severities Among Patients with Nonvalvular Atrial Fibrillation in a Managed Care PopulationDeitelzweig, Steven, Pinsky, Brett, Buysman, Erin, Lacey, Michael, Jing, Yonghua, Wiederkehr, Daniel and Graham, John (2012). Association Between Age and Bleeding Events of Different Severities Among Patients with Nonvalvular Atrial Fibrillation in a Managed Care Population. 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta Ga, Dec 08-11, 2012. AMER SOC HEMATOLOGY. |
|
2012 Conference Publication Impact of Hyponatremia On Health Care Resource Utilization in Decompensated Cirrhosis PatientsDeitelzweig, S., Amin, A., Lin, J., Christian, R., Baumer, D. and Lowe, T. (2012). Impact of Hyponatremia On Health Care Resource Utilization in Decompensated Cirrhosis Patients. ELSEVIER SCIENCE INC. |
|
2012 Conference Publication Total Medical Costs Avoided with Apixaban Versus Aspirin Treatment Among Atrial Fibrillation Patients Unable or Unwilling to Take Warfarin, Based On the Averroes Trial Results: Acc Oral ContributionsAmin, Alpesh N., Deitelzweig, Steven, Jing, Yonghua, Makenbaeva, Dinara, Wiederkehr, Daniel, Lin, Jay and Graham, John (2012). Total Medical Costs Avoided with Apixaban Versus Aspirin Treatment Among Atrial Fibrillation Patients Unable or Unwilling to Take Warfarin, Based On the Averroes Trial Results: Acc Oral Contributions. 61st Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC), Chicago Il, Mar 24-27, 2012. ELSEVIER SCIENCE INC. |
|
2012 Conference Publication Comparison of Total Medical Cost Avoidance with the Usage of New Oral Anticoagulants Instead of Warfarin Among Atrial Fibrillation Patients, Based On the Aristotle, Re-Ly and Rocket-Af TrialsDeitelzweig, Steven, Amin, Alpesh, Jing, Yonghua, Makenbaeva, Dinara, Makenbaeva, Dinara, Wiederkehr, Daniel, Lin, Jay and Graham, John (2012). Comparison of Total Medical Cost Avoidance with the Usage of New Oral Anticoagulants Instead of Warfarin Among Atrial Fibrillation Patients, Based On the Aristotle, Re-Ly and Rocket-Af Trials. 61st Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC), Chicago Il, Mar 24-27, 2012. ELSEVIER SCIENCE INC. |
|
2011 Conference Publication Impact of Hyponatremia on Inpatient Mortality and Hospital Readmission Rates in Hospitalized Patients with Heart FailureDeitelzweig, Steven, Amin, Alpesh, Lin, Jay, Belk, Kathy, Baumer, Dorothy and Lowe, Timothy (2011). Impact of Hyponatremia on Inpatient Mortality and Hospital Readmission Rates in Hospitalized Patients with Heart Failure. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS. |
|
2011 Conference Publication Consequences of Hyponatremia on Intensive Care Unit Cost and Length of Stay in Heart Failure PatientsAmin, Alpesh, Deitelzweig, Steven, Lin, Jay, Belk, Kathy, Baumer, Dorothy and Lowe, Timothy (2011). Consequences of Hyponatremia on Intensive Care Unit Cost and Length of Stay in Heart Failure Patients. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS. |
